BKHA · Black Hawk Acquisition Corp
$11.88
+0.03 (+0.28%)
At close · Aug 27
Going-concern doubt
— flagged Jul 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination Period, the Company's board of directors would proceed to commence voluntary liquidation and thereby a formal dissolution of the Company. There is no assurance that the Company's plans to consummate a Business Combination will be successful within the Combination Period. As a result, management has determined that such additional condition also raises substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jul 15, 2026
Market Cap
$49.21M
Shares
4.15M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Luo Feng | Chief Scientific Officer of Vesicor | Appointed | 2026-03-17 |
| Michael Tolentino | Chief Executive Officer ("CEO") of Vesicor Therapeutics, Inc. | Appointed | 2026-03-17 |
| Frederick Woodruff Field | member of its board of directors | Appointed | 2026-02-03 |
| Mitchell Creem | Chief Financial Officer | Appointed | 2026-02-03 |
| Terry W. Protto | Chairperson of the Compensation Committee | Appointed | 2025-06-04 |
| Daniel M. McCabe | Chairperson of the Compensation Committee | Resigned | 2025-06-04 |
| Daniel M. McCabe | Chairperson of the Audit Committee | Appointed | 2025-06-04 |
| Brandon Miller | member of the Company's board of directors and the Chairperson of the Audit Committee | Terminated | 2025-06-04 |
| Jonathan Ginsberg | director | Appointed | 2024-04-24 |
| Jonathan Ginsberg | Chief Operating Officer | Appointed | 2024-04-24 |